We determined that miR-550-1 expression was decreased in two independent primary AML patient cohorts, and elevated miR-550-1 expression was associated with higher hemoglobin (Hb) levels (Table 2), potentially contributing to improved patient prognosis. Here, GSTM1 is linked to acute myeloid leukemia.